eGenesis Company
Xenotransplant
Investors
Headquarters:
USA
Employee Number:
11-50
Industry:
Risk Mitigation
Total Funding:
$265.00
Estimated Revenue:
$10M to $50M
Investors Number:
27
Last Funding Date:
2021
Investor Type:
Late Stage Venture
Founded Date:
2014
Last Funding Type:
Series C